Billionaire Microsoft co-founder Bill Gates is supporting Alzheimer’s disease research by investing $50 million in the Dementia Discovery Fund.
The DDF is a venture capital fund that brings together industry and government to solicit treatments for the brain-wasting disease. It provides
venture finance for startup ventures developing a treatment for Alzheimer’s and brain-related diseases.
Gates said that the number of people suffering from Alzheimer’s and other forms of dementia is growing and diseases are taking an emotional and financial toll as pole live longer. It’s a huge and growing problem, Gates said.
Even with decades of scientific research, no treatment found which can slow the progression of Alzheimer‘s. current drugs can only ease some of the symptoms.
Gates hopes that in the next 10 years our scientific research will have some powerful drugs, but it’s possible that won’t be achieved.
“I know how awful it is to watch people you love struggle as the disease robs them of their mental capacity… It feels a lot like you’re experiencing a gradual death of the person that you knew,” Gates said about the dementia investment.
Gates also said that, some of the members of his family have suffered from Alzheimer‘s, but that not the single reason for this investment.
The investment would help researchers to discover patterns and identify new pathways for treatment, he said.
Gates promised that along with the $50 million investment in DDF, additionally, he is investing $50 million for start-ups, to award a grant to build a global dementia data platform.